CLEVELAND BIOLABS INC·4

Sep 7, 6:08 AM ET

Fonstein Michael 4

4 · CLEVELAND BIOLABS INC · Filed Sep 7, 2011

Insider Transaction Report

Form 4
Period: 2011-09-02
Fonstein Michael
DirectorCEO, President
Transactions
  • Purchase

    Common Stock, par value $0.005 per share

    2011-09-02$2.27/sh+2,200$4,9941,253,400 total

Documents

1 file
  • 4
    v234197_4.xmlPrimary

    OWNERSHIP DOCUMENT